Skip to main content
Premium Trial:

Request an Annual Quote

N-of-One to Support Oncology Testing at BloodCenter of Wisconsin

NEW YORK (GenomeWeb) – N-of-One said today that the BloodCenter of Wisconsin has selected it to provide interpretation services for HemeOnc, a next-generation sequencing-based panel developed by the not-for-profit organization for the diagnosis, prognosis, and risk stratification of hematologic malignancies.

"BloodCenter of Wisconsin selected N-of-One because of their high quality clinical interpretation which addresses the specific features of each patient’s molecular profile," D. P. Dash, director of the molecular oncology laboratory at BloodCenter of Wisconsin, said in a statement. BloodCenter's diagnostic laboratories offer molecular testing for diagnostic and prognostic markers within acute myeloid leukemia, myeloproliferative neoplasms, and chronic myelogenous leukemia. Its test menus are built around testing algorithms that are recommended by peer-reviewed treatment guidelines such as the National Comprehensive Cancer Network and World Health Organization.

N-of-One provides clinical interpretation that is scalable and cost-effective, as well as patient-specific, it said.

Financial and other terms of the agreement were not disclosed.


The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.